Derek Raghavan

14PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.

Nilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose

|Jul 15, 2024
Two Centuries Have Shown That Voltaire May No Longer Be Correct About Doctors …At Least Those Treating Advanced Prostate Cancer.

Donald Skip Trump, Derek Raghavan

|Dec 07, 2023
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer.

Landon C Brown, Jason Zhu, Elizabeth Mauer

|Jul 15, 2022
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.

Carol J Farhangfar, Gregory T Scarola, Victoria A Morris

|Mar 23, 2022
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers.

Mohamed E Salem, Sherif M El-Refai, Wei Sha

|Jun 08, 2021
Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem.

Derek Raghavan, Nicole A Keith, Hughes R Warden

Pageof 3

Frequent Collaborators

3 joint publications

James Symanowski

1 joint publications

Nicole A Keith

1 joint publications

Seungjean Chai

1 joint publications

Sherif M El-Refai